ANDA 65281, held by Bausch. Doxycycline Hyclate.
As of Nov 16, 2026, ANDA 65281 (Doxycycline Hyclate), held by Bausch, was first approved by FDA on Dec 21, 2005, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 21, 2005 | Original application | Approved | None posted |
| Doxycycline HyclateEQ 75MG BASE · capsule, delayed release;oral | Doxycycline Hyclate | Discontinued |
| Doxycycline HyclateEQ 100MG BASE · capsule, delayed release;oral | Doxycycline Hyclate | Discontinued |
| Dec 21, 2015 | Supplement 2Labeling | Approved | None posted |
| Dec 21, 2005 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters